Home Blog Page 25

Blog

Pharma Marketing Blog

Random

Pfizer’s Harem Styled Gulfstream G550 for Sale: US $35,500,000 (Lightly Used)

Pharma Guy - May 29, 2009

FDA Fan Club Launched on Facebook

Pharma Guy - February 17, 2010

FDA Says Men Who Receive Drugs for “Low-T” Have 30% Increased...

Pharma Guy - September 5, 2014

It’s the land of success!

Pharma Guy - February 2, 2005

Pharma Super Bowl Ads Score Poorly

Pharma Guy - February 12, 2007

Pharma PR: It’s All About Defending Drug Prices

Pharma Guy - February 23, 2006

mHealth Apps: Overwhelming Choice, Limited Proven Efficacy, Security Issues

Pharma Guy - September 17, 2015

“Making A Killing:” Scientology Video Blasts the Pyschiatry-Drug Industry-FDA Complex!

Pharma Guy - November 25, 2008

I’m Off to FDA Hearing: Here’s What I Plan to Show...

Pharma Guy - November 11, 2009

An Analysis of DDMAC Warning Letters Regarding Risk Information in Broadcast...

Pharma Guy - April 8, 2010

1...242526...241 Page 25 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Strategic pharmaceutical launch planning showing healthcare experts, scientific collaboration, and market preparation activities before drug approval.

The Invisible Launch: How Blockbuster Brands Build Demand Before Approval

June 16, 2026

Pharmaceutical marketing concept showing competitive gravity attracting scientific influence, stakeholder engagement, healthcare access, and market leadership.

Beyond Market Share: Why Competitive Gravity Determines Who Wins the Category

June 15, 2026

Pharmaceutical evidence supply chain showing clinical data moving from research and publications to medical guidelines, healthcare professionals, and commercial market influence.

The Evidence Supply Chain: How Clinical Data Becomes Commercial Influence

June 15, 2026